Intracranial complications of mucormycosis: An experimental model and clinical review

Laryngoscope

Volumn 102, Issue 6, 1992, Pages 656-662

  Anand, Vinod K ^a   Alemar, Gilberto ^a   Griswold, John A ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; IRON; TRANSFERRIN;

ADOLESCENT; ADULT; ALLOXAN DIABETES MELLITUS; ANIMAL MODEL; ANIMAL TISSUE; BRAIN INFECTION; BRAIN SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE DEFICIENCY; IRON CHELATION; MALE; MOUSE; MUCORMYCOSIS; NONHUMAN; NOSE INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANASAL SINUS; PRIORITY JOURNAL; RHIZOPUS; SCHOOL CHILD; SURVIVAL; TRANSFERRIN BLOOD LEVEL;

ADULT; ALLOXAN; AMPHOTERICIN B; ANIMAL; BRAIN ABSCESS; BRAIN DISEASES; CHILD; DEFEROXAMINE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE SUSCEPTIBILITY; ETHMOID SINUS; FEMALE; HUMAN; MALE; MICE; MICE, INBRED STRAINS; MIDDLE AGE; MUCORMYCOSIS; PARANASAL SINUS DISEASES; RHIZOPUS;

EID: 0026723948     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1288/00005537-199206000-00011     Document Type: Article

References (36)

1. Blitzer, A., Lawson, W., Meyers, B.R., et al.: Patient Survival Factors in Paranasal Sinus Mucormycosis. Laryngoscope, 90: 635-648, 1980.
2. Maniglia, A.J., Mintz, D.H. and Novak, S.: Cephalic Phycomycosis: A Report of Eight Cases. Laryngoscope, 92: 755-760, 1982.
3. Rangel-Guerra, R., Martinez, H.R. and Saenz, C: Mucormycosis: Report of 11 Cases. Arch Neurol, 42: 578-581, 1985.
4. Abedi, E., Sismanis, A., Choi, K., et al.: Twenty-Five Years' Experience Treating Cerebro-Rhino-Orbital Mucormycosis. Laryngoscope, 94: 1060-1062, 1984.
5. Parfrey, N.A.: Improved Diagnosis and Prognosis of Mucormycosis: A Clinicopathologic Study of 33 Cases. Medicine, 65: 113-123, 1986.
6. Couch, L., Theilen, F. and Mader, J.T.: Rhinocerebral Mucormycosis With Cerebral Extension Successfully Treated With Adjunctive Hyperbaric Oxygen Therapy. Arch Otolaryngol Head Neck Surg, 114: 791-794,1988.
7. Glass, E.J., Stewart, J. and Weir, D.M.: Altered Immune Function in Alloxan-Induced Diabetes in Mice. Clin. Exp. Immunol, 65: 614-621, 1986.
8. Abe, E, Skibuya, H., Tatyana, M., et al.: Mucormycosis in Diabetic Ketoacidosis Role of Unbound Iron Binding Capacity of Transferrin. Acta. Pathol Jpn., 36:1507-1512,1986.
9. Pillsbury, H.C. and Fischer, N.D.: Rhinocerebral Mucormycosis. Arch. Otolaryngol, 103: 600-604, 1977.
10. Ochi, J.W., Harris, J.P., Feldman, J.I., et al.: Rhinocerebral Mucormycosis: Results of Aggressive Surgical Debridement and Amphotericin B. Laryngoscope, 98: 1339-1342, 1988.
11. Ferguson, B.J., Mitchell, T.G., Moon, R., et al.: Adjunctive Hyperbaric Oxygen for Treatment of Rhinocerebral Mucormycosis. Rev Infect Dis, 10: 551-559, 1988.
12. McNulty, J.S.: Rhinocerebral Mucormycosis: Predisposing Factors. Laryngoscope, 92:1140-1143,1982.
13. Williams, G., Kleinschmidt-DeMasters, B.K and Solomon, W.: Rhinocerebral Mucormycosis and Low Folate Level. Surg. Neurol., 27: 500, 1987.
14. Gluskin, M., Solomon, M.P., Gold, B., et al.: Mucormycotic Slough of Nasal Floor and Palate in the Anephric Patient. JADA, 98:224-227,1979.
15. Windus, D.W, Stokes, T.J., Julian, B.A., et al: Fatal Rhizopus Infections in Hemodialysis Patients Receiving Deferoxamine. Ann Int Med., 107:678-680,1987.
16. Abramson, E., Wilson, D. and Arky, R.A.: Rhinocerebral Phycomycosis in Association with Diabetic Ketoacidosis: Report of Two Cases and a Review of Clinical and Experimental Experience with Amphotericin B Therapy. Ann. Intern. Med., 66: 735-742, 1967.
17. Gaulton, G.N., Schwartz, J.L. and Eardley, D.D.: Assessment of the Diabetogenic Drugs Alloxan or Streptozotocin as Models for the Study of Immune Defects in Diabetic Mice. Dia-betalogia, 28:7 69-776, 1985.
18. Waldorf, A.R. and Drammond, R.D.: Cerebral Mucormycosis in Diabetic Mice after Intrasinus Challenge. Inf Immunol, 44:194-195, 1984.
19. Schofield, R.A. and Baker, R.D.: Experimental Mucormycosis (Rhizopus Infections) in Mice: The Failure of Chronic Alloxan Diabetes to Modify Host Susceptibility. Arch Pathol, 61:407-415, 1956.
20. Corbel, M.J. and Eades, S.N.: Factors Determining the Susceptibility of Mice to Experimental Phycomycosis. J Med Micro. biol, 8:551-564,1975.
21. Cutsem, J.V. and Boelaert, J.R.: Effects of Deferoxamine, Feroxamine and Iron on Experimental Mucormycosis (Zy-gomycosis). Kidney Int, 36:1061-1068,1989.
22. Yanagisawa, E., Friedman, S., Kundargi, R.S., et al.: Rhinocerebral Phycomycosis. Laryngoscope, 87: 1319-1335, 1977.
23. Lowe, J.T., Jr. and Hudson, W.R.: Rhinocerebral Phycomycosis and Internal Carotid Thrombosis. Arch Otolaryngol, 101: 100-103, 1975.
24. Ferry, A.P. and Abedi, S.: Diagnosis and Management of RhinoOrbitocerebral Mucormycosis. (Phycomycosis): A Report of 16 Personally Observed Cases. Ophthalmology, 90:1096-1104, 1983.
25. Hameroff, S.B., Eckholdt, J.W. and Lindenberg, R.: Cerebral Phycomycosis in a Heroin Addict. Neurology, 20: 261-265, 1970.
26. Chmel, H. and Grieco, M.H.: Cerebral Mucormycosis and Renal Aspergillosis in Heroin Addicts without Endocarditis. Am. J Med. Sci., 266: 225-231, 1973.
27. Masucci, E.F., Fabara, J.A., Saini, N., et al: Cerebral Mucormycosis (Phycomycosis) in a Heroin Addict. Arch. Neurol., 39:304-306,1982.
28. Woods, K.F. and Hanna, B.J.: Brain Stem Mucormycosis in a Narcotic Addict With Eventual Recovery. Am J Med, 80: 126-128, 1986.
29. Kasantikul, V., Shuangshoti, S. and Taecholarn, C: Primary Phycomycosis of the Brain in Heroin Addicts. Surg Neurol, 28: 468-472, 1987.
30. Stave, G.M., Heimberger, T. and Kerkering, T.M.: Zygomycosis of the Basal Ganglia in Intravenous Drug Users. Am J Med, 86: 115-117, 1989.
31. Fong, K.M., Seneviratne, E.M.E. and McCormack, J.G.: Mucor Cerebral Abscess Associated with Intravenous Drug Abuse. Aust NZJ Med,.20: 74-77, 1990.
32. Cuadrado, L.M., Guerrero, A., Garcia Asenjo, J.A., et al: Cerebral Mucormycosis in Two Cases of Acquired Immunodeficiency Syndrome. Arch Neurol, 45: 109-111, 1988.
33. Hughes, C.E., Harris, C, Moody, J.A., et al.: In Vitro Activities of Amphotericin B in Combination With Four Antifungal Agents and Rifampin Against Aspergillus spp. Antimicrob Agents Chemother, 25: 560-562, 1984.
34. Christenson, J.C., Shalit, I., Welch, D.F., et al: Synergistic Action of Amphotericin B and Rifampin Against Rhizopus Species. Antimicrob Agents Chemother, 31: 1775-1778, 1987.
35. Price, J.C. and Stevens, D.L.: Hyperbaric Oxygen in the Treatment of Rhinocerebral Mucormycosis. Laryngoscope, 90:737-747, 1980.
36. Cairney, W.J.: The Effect of Hyperbaric Oxygen on Certain Growth Features of Four Dermatophytes. Frank J. Seiley Research Laboratory Technical Report, pp. 80-85, 1980.